BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) said its flagship anti-underarm-sweating treatment provided long-term efficacy in a Phase III trial […]
Source: BizWest
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
WESTMINSTER — Gene therapy maker ARCA biopharma Inc. (Nasdaq: ABIO) has filed an initial application to study whether its anti-blood…
ESTES PARK — Several upcoming public meetings, including one this week, may heal some rifts between Larimer County commissioners and…
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
